Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: implications for the ability of serological assays to predict immunity

medRxiv(2021)10.1101/2021.07.02.21259939Source: DataRank Database

Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: implications for the ability of serological assays to predict immunity is a research paper published in medRxiv (2021). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (19)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Helen Wise ORCID,Kate Templeton ORCID,Becky Batchelor,Maria Squires ORCID,Kirsty McCance ORCID

Live enrichment

PubMed:34268524 OpenAlex:https://openalex.org/W3182155919

National Institutes of Health

Grant: 2R01AI078788-12A1

Overcoming Host Restriction Factors to Develop Better Animal Models for HIV/AIDS

National Institutes of Health

Grant: 5R01AI050111-02

DETERMINANTS OF INFECTIOUS HIV-1 PARTICLE PRODUCTION

greenLicense: cc-by-nc-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2021/07/07/2021.07.02.21259939.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.07.02.21259939

repositoryhttps://doi.org/10.1101/2021.07.02.21259939

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34268524

Fields of Study

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesCOVID-19 Clinical Research Studies0301 basic medicine03 medical and health sciences

Keywords

SerologyAntibodyNeutralizing antibodyVirologyTiterNeutralizationBiologyImmunityAntibody titerImmunologyPopulationImmune systemMedicineArticle

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being